Correspondence 0001493152-23-029392 from LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Date: Aug. 18, 2023 · CIK: 0001335105 · Accession: 0001493152-23-029392

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-273932

Date

August 11, 2023

Author

Chief

Form

CORRESP

Company

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Letter

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

East Colorado Boulevard, Suite 180

Pasadena, California 91101

August 18, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F. Street, N.E.

Washington, D.C. 20549

Re: Lixte Biotechnology Holdings, Inc.

Registration Statement on Form S-3

Filed August 11, 2023

File No. 333-273932

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Lixte Biotechnology Holdings, Inc., a Delaware corporation, respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 p.m., Eastern Time, on Monday, August 21, 2023, or as soon thereafter as is practicable. Please call our counsel, David Ficksman of TroyGould PC at 310-789-1290 to provide notice of effectiveness.

Very
truly yours,
LIXTE
BIOTECHNOLOGY HOLDINGS, INC.

Show Raw Text

CORRESP
1
filename1.htm

LIXTE
BIOTECHNOLOGY HOLDINGS, INC.

680
East Colorado Boulevard, Suite 180

Pasadena,
California 91101

August
18, 2023

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F. Street, N.E.

Washington,
D.C. 20549

    Re:
    Lixte
    Biotechnology Holdings, Inc.

    Registration
    Statement on Form S-3

    Filed
    August 11, 2023

    File
    No. 333-273932

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, Lixte Biotechnology Holdings, Inc., a Delaware corporation, respectfully
requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective
at 4:00 p.m., Eastern Time, on Monday, August 21, 2023, or as soon thereafter as is practicable. Please call our counsel, David Ficksman
of TroyGould PC at 310-789-1290 to provide notice of effectiveness.

    Very
    truly yours,

    LIXTE
    BIOTECHNOLOGY HOLDINGS, INC.

    By:
    /s/
    John Kovach

    John
    Kovach

    Chief
     Executive Officer

SecProbe.io